Skye Bioscience discusses Q4 2024 earnings and future plans

Skye Bioscience, Inc. held its fourth-quarter earnings call on March 20, 2025. The call included key executives such as President and CEO Punit Dhillon and CFO Kaitlyn Arsenault. During the call, they discussed financial results and company activities from the past year. Bernie Hertel, Head of Investor Relations, welcomed participants and introduced the main speakers. He also noted that some remarks may include forward-looking statements, which come with inherent risks and uncertainties. The executives highlighted their ongoing development projects and their future plans. They remain optimistic about their goals but reminded listeners that actual outcomes could vary. After the presentations, a question-and-answer session allowed analysts to seek further clarity on the company's direction and financial health. Overall, the call aimed to provide insights into Skye Bioscience's recent performance and plans moving forward.